Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,121 | 742 | 1,792 | 1,392 | 1,970 |
| Marketable Securities | 69 | 77 | 78 | 76 | 78 |
| Receivables | 626 | 636 | 1,262 | 856 | 48 |
| Inventories | N/A | N/A | N/A | N/A | 21 |
| Other current assets | 535 | 526 | 0 | 514 | 500 |
| TOTAL | $2,494 | $2,129 | $3,480 | $2,987 | $2,903 |
| Non-Current Assets | |||||
| PPE Net | 7,954 | 564 | 572 | 574 | 567 |
| Investments And Advances | 4,106 | 4,111 | 4,021 | 3,681 | 3,403 |
| Other Non-Current Assets | 2,038 | 2,516 | 2,662 | 2,338 | 3,608 |
| TOTAL | $14,098 | $7,192 | $7,255 | $6,592 | $7,578 |
| Total Assets | $16,592 | $9,320 | $10,735 | $9,580 | $10,481 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 480 | 979 | 1,011 | 360 | 452 |
| Accrued Expenses | 3,558 | 3,441 | 2,763 | 2,910 | 1,202 |
| Other current liabilities | 80 | 80 | 11 | 11 | 11 |
| TOTAL | $5,363 | $5,773 | $5,075 | $5,544 | $3,894 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,217 | 3,966 | 3,999 | 437 | 965 |
| TOTAL | $2,167 | $3,915 | $3,926 | $800 | $893 |
| Total Liabilities | $7,530 | $9,687 | $9,000 | $6,343 | $4,787 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,232 | 3,951 | 3,308 | 3,308 | 3,263 |
| Common Shares | 5 | 3 | 33 | 3 | 33 |
| Retained earnings | -62,309 | -58,992 | -56,728 | -54,904 | -50,041 |
| Other shareholders' equity | -296 | -456 | -619 | -800 | -1,793 |
| TOTAL | $9,062 | $-367 | $1,735 | $3,236 | $5,693 |
| Total Liabilities And Equity | $16,592 | $9,320 | $10,735 | $9,580 | $10,481 |